Non-alcoholic Fatty liver Disease in Patients with Psoriasis - Therapeutic Implications

Elżbieta Halina Kłujszo; Piotr Parcheta; Anna B. Witkowska; Beata Kręcisz

doi:10.5114/ada.2019.83983

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2020
vol. 37

Send email

Copy url:

abstract:

Review paper

Non-alcoholic Fatty liver Disease in Patients with Psoriasis - Therapeutic Implications

Elżbieta Halina Kłujszo

¹

,

Piotr Parcheta

¹

,

Anna B. Witkowska

²

,

Beata Kręcisz

³

Department of Dermatology, Regional Hospital, Kielce, Poland

Graduate of Medical University, Szeged, Hungary

Faculty of Medicine and Health Science, Jan Kochanowski University, Kielce, Poland

Adv Dermatol Allergol 2020; XXXVII (4): 468-474

DOI: https://doi.org/10.5114/ada.2019.83983

Online publish date: 2019/07/25

View full text Get citation

Non-alcoholic fatty liver disease (NAFLD) is the most common liver pathology in the West. Psoriatic patients are at higher risk of having NAFLD, and at higher risk of experiencing the more severe form of the disease, with poorer outcomes. The components of the metabolic syndrome – obesity, lipid abnormalities, hypertension, and type 2 diabetes – significantly correlate with NAFLD progression. The inflammatory state present in psoriasis plays a significant role in development of NAFLD and the metabolic syndrome. All patients with psoriasis and insulin resistance and risk factors for metabolic syndrome should also been screened for NAFLD, and planning of the treatment options should always take into consideration the possible risks for the liver, especially in patients with NAFLD.

keywords:

Non-alcoholic Fatty liver Disease in Patients with Psoriasis - Therapeutic Implications

Elżbieta Halina Kłujszo 1 , Piotr Parcheta 1 , Anna B. Witkowska 2 , Beata Kręcisz 3

psoriasis, liver disease, methotrexate, biologic agents

Elżbieta Halina Kłujszo

¹

,

Piotr Parcheta

¹

,

Anna B. Witkowska

²

,

Beata Kręcisz

³